U.S. Markets open in 2 hrs 53 mins

Top Ranked Momentum Stocks to Buy for October 16th

Zacks Equity Research
1 / 6

Should You Buy Sempra Energy (SRE) Ahead of Earnings?

Sempra Energy (SRE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 16th:

Newpark Resources, Inc. (NR): This oil and gas exploration company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 2.4% over the last 60 days.

Newpark Resources, Inc. Price and Consensus

Newpark Resources, Inc. Price and Consensus

Newpark Resources, Inc. price-consensus-chart | Newpark Resources, Inc. Quote

Newpark’s shares gained 4.8% over the last one month more than S&P 500’s loss of -5.3%. The company possesses a Momentum Score of B.

Newpark Resources, Inc. Price

Newpark Resources, Inc. Price

Newpark Resources, Inc. price | Newpark Resources, Inc. Quote

Trinity Industries, Inc. (TRN): This industrial company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 3.8% over the last 60 days.

Trinity Industries, Inc. Price and Consensus

Trinity Industries, Inc. Price and Consensus

Trinity Industries, Inc. price-consensus-chart | Trinity Industries, Inc. Quote

Trinity’s shares gained 0.1% over the last one month. The company possesses a Momentum Score of A.

Trinity Industries, Inc. Price

Trinity Industries, Inc. Price

Trinity Industries, Inc. price | Trinity Industries, Inc. Quote

Actinium Pharmaceuticals, Inc. (ATNM): This operator of a clinical-stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.2% over the last 60 days.

Actinium Pharmaceuticals, Inc. Price and Consensus

Actinium Pharmaceuticals, Inc. Price and Consensus

Actinium Pharmaceuticals, Inc. price-consensus-chart | Actinium Pharmaceuticals, Inc. Quote

Actinium’s shares gained 4.8% over the last one month. The company possesses a Momentum Score of A.

Actinium Pharmaceuticals, Inc. Price

Actinium Pharmaceuticals, Inc. Price

Actinium Pharmaceuticals, Inc. price | Actinium Pharmaceuticals, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Trinity Industries, Inc. (TRN) : Free Stock Analysis Report
 
Newpark Resources, Inc. (NR) : Free Stock Analysis Report
 
Actinium Pharmaceuticals, Inc. (ATNM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research